Intercontinental Wealth Advisors’s Kyntra Bio KYNB Stock Holding History

Intercontinental Wealth Advisors’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$258K	Hold	3,826	–	–	0.06%	280
2023 Q1	$1.78M	Sell	3,826 -3,826	-50%	-$2.02M	0.46%	35
2022 Q4	$3.06M	Hold	7,652	–	–	0.91%	15
2022 Q3	$2.49M	Hold	7,652	–	–	0.78%	17
2022 Q2	$2.02M	Hold	7,652	–	–	0.55%	27
2022 Q1	$2.3M	Hold	7,652	–	–	0.52%	22
2021 Q4	$2.7M	Hold	7,652	–	–	0.57%	22
2021 Q3	$1.96M	Hold	7,652	–	–	0.46%	30
2021 Q2	$5.09M	Hold	7,652	–	–	1.01%	9
2021 Q1	$6.64M	Hold	7,652	–	–	1.45%	8
2020 Q4	$7.09M	Buy	+7,652	New	+$8.04M	1.71%	8
2019 Q4	–	Sell	-32	Closed	-$30K	–	376
2019 Q3	$30K	Hold	32	–	–	0.02%	250
2019 Q2	$36K	Hold	32	–	–	0.02%	229
2019 Q1	$43K	Hold	32	–	–	0.02%	236
2018 Q4	$37K	Buy	+32	New	+$36K	0.02%	242

Other funds holding KYNB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Intercontinental Wealth Advisors's KYNB Position: Q2 2023 in Review

Intercontinental Wealth Advisors held its Kyntra Bio (KYNB) position steady in Q2 2023 at 3,826 shares worth $258K. The position accounts for 0.06% of the portfolio, ranked #280.

Intercontinental Wealth Advisors first reported a position in KYNB in Q4 2018 and has held it in 15 quarters since. The position peaked at $7.09M in Q4 2020. 152 funds tracked by Wall St. Rank hold KYNB as of Q2 2023.

Intercontinental Wealth Advisors held 3,826 shares of Kyntra Bio worth $258K as of Q2 2023.
Intercontinental Wealth Advisors left its Kyntra Bio share count unchanged in Q2 2023.
Kyntra Bio made up 0.06% of Intercontinental Wealth Advisors's portfolio in Q2 2023, its #280 holding.
Intercontinental Wealth Advisors first reported a position in Kyntra Bio in Q4 2018 and has held it in 15 quarters since.
Intercontinental Wealth Advisors's Kyntra Bio position peaked at $7.09M in Q4 2020.
152 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2023.

Based on Intercontinental Wealth Advisors's 13F filing for Q2 2023, filed 21 Jul 2023.